- Home
- CLLS vs NBH Comparison
CLLS vs NBH Comparison
Compare CLLS & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- NBH
- Stock Information
- Founded
- CLLS 1999
- NBH 2002
- Country
- CLLS France
- NBH United States
- Employees
- CLLS N/A
- NBH N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- CLLS Health Care
- NBH Finance
- Exchange
- CLLS Nasdaq
- NBH Nasdaq
- Market Cap
- CLLS 299.0M
- NBH 292.3M
- IPO Year
- CLLS 2007
- NBH N/A
- Fundamental
- Price
- CLLS $3.15
- NBH $10.44
- Analyst Decision
- CLLS Buy
- NBH
- Analyst Count
- CLLS 1
- NBH 0
- Target Price
- CLLS $4.00
- NBH N/A
- AVG Volume (30 Days)
- CLLS 76.4K
- NBH 85.9K
- Earning Date
- CLLS 11-03-2025
- NBH 01-01-0001
- Dividend Yield
- CLLS N/A
- NBH 4.34%
- EPS Growth
- CLLS N/A
- NBH N/A
- EPS
- CLLS N/A
- NBH 0.12
- Revenue
- CLLS $63,438,000.00
- NBH N/A
- Revenue This Year
- CLLS N/A
- NBH N/A
- Revenue Next Year
- CLLS $66.76
- NBH N/A
- P/E Ratio
- CLLS N/A
- NBH $87.04
- Revenue Growth
- CLLS 223.09
- NBH N/A
- 52 Week Low
- CLLS $1.10
- NBH $8.75
- 52 Week High
- CLLS $3.35
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- CLLS 54.47
- NBH 81.89
- Support Level
- CLLS N/A
- NBH $9.77
- Resistance Level
- CLLS $3.35
- NBH $9.95
- Average True Range (ATR)
- CLLS 0.15
- NBH 0.09
- MACD
- CLLS -0.09
- NBH 0.05
- Stochastic Oscillator
- CLLS 94.03
- NBH 97.93
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.